Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Etanercept suppresses arteritis in a murine model of kawasaki disease: a comparative study involving different biological agents.

Ohashi R, Fukazawa R, Watanabe M, Tajima H, Nagi-Miura N, Ohno N, Tsuchiya S, Fukuda Y, Ogawa S, Itoh Y.

Int J Vasc Med. 2013;2013:543141. doi: 10.1155/2013/543141. Epub 2013 Mar 31.

2.

Characterization of a murine model with arteritis induced by Nod1 ligand, FK565: a comparative study with a CAWS-induced model.

Ohashi R, Fukazawa R, Watanabe M, Hashimoto K, Suzuki N, Nagi-Miura N, Ohno N, Shimizu A, Itoh Y.

Mod Rheumatol. 2017 Feb 2:1-19. doi: 10.1080/14397595.2017.1287150. [Epub ahead of print]

PMID:
28150515
3.

Mizoribine provides effective treatment of sequential histological change of arteritis and reduction of inflammatory cytokines and chemokines in an animal model of Kawasaki disease.

Takahashi K, Oharaseki T, Nagao T, Yokouchi Y, Yamada H, Nagi-Miura N, Ohno N, Saji T, Okazaki T, Suzuki K.

Pediatr Rheumatol Online J. 2011 Sep 29;9(1):30. doi: 10.1186/1546-0096-9-30.

4.

The role of TNF-α in a murine model of Kawasaki disease arteritis induced with a Candida albicans cell wall polysaccharide.

Oharaseki T, Yokouchi Y, Yamada H, Mamada H, Muto S, Sadamoto K, Miura N, Ohno N, Saji T, Naoe S, Takahashi K.

Mod Rheumatol. 2014 Jan;24(1):120-8. doi: 10.3109/14397595.2013.854061.

PMID:
24261768
5.

[Histopathological examination and analysis of mortality in DBA/2 mouse vasculitis induced with CAWS, a water-soluble extracellular polysaccharide fraction obtained from Candida albicans].

Hirata N, Ishibashi K, Ohta S, Hata S, Shinohara H, Kitamura M, Miura N, Ohno N.

Yakugaku Zasshi. 2006 Aug;126(8):643-50. Japanese.

6.

Induction of coronary arteritis with administration of CAWS (Candida albicans water-soluble fraction) depending on mouse strains.

Nagi-Miura N, Shingo Y, Adachi Y, Ishida-Okawara A, Oharaseki T, Takahashi K, Naoe S, Suzuki K, Ohno N.

Immunopharmacol Immunotoxicol. 2004;26(4):527-43.

PMID:
15658603
7.

Administration of human immunoglobulin suppresses development of murine systemic vasculitis induced with Candida albicans water-soluble fraction: an animal model of Kawasaki disease.

Takahashi K, Oharaseki T, Yokouchi Y, Miura NN, Ohno N, Okawara AI, Murata H, Naoe S, Suzuki K.

Mod Rheumatol. 2010 Apr;20(2):160-7. doi: 10.1007/s10165-009-0250-5. Epub 2009 Nov 27.

PMID:
19943075
9.

Lethal and severe coronary arteritis in DBA/2 mice induced by fungal pathogen, CAWS, Candida albicans water-soluble fraction.

Nagi-Miura N, Harada T, Shinohara H, Kurihara K, Adachi Y, Ishida-Okawara A, Oharaseki T, Takahashi K, Naoe S, Suzuki K, Ohno N.

Atherosclerosis. 2006 Jun;186(2):310-20. Epub 2005 Sep 12.

PMID:
16157343
10.

Augmented TLR2 expression on monocytes in both human Kawasaki disease and a mouse model of coronary arteritis.

Lin IC, Kuo HC, Lin YJ, Wang FS, Wang L, Huang SC, Chien SJ, Huang CF, Wang CL, Yu HR, Chen RF, Yang KD.

PLoS One. 2012;7(6):e38635. doi: 10.1371/journal.pone.0038635. Epub 2012 Jun 21.

11.

TNF-α is superior to conventional inflammatory mediators in forecasting IVIG nonresponse and coronary arteritis in Chinese children with Kawasaki disease.

Hu P, Jiang GM, Wu Y, Huang BY, Liu SY, Zhang DD, Xu Y, Wu YF, Xia X, Wei W, Hu B.

Clin Chim Acta. 2017 May 16;471:76-80. doi: 10.1016/j.cca.2017.05.019. [Epub ahead of print]

PMID:
28526535
12.

Neutrophil activation and arteritis induced by C. albicans water-soluble mannoprotein-beta-glucan complex (CAWS).

Ishida-Okawara A, Nagi-Miura N, Oharaseki T, Takahashi K, Okumura A, Tachikawa H, Kashiwamura S, Okamura H, Ohno N, Okada H, Ward PA, Suzuki K.

Exp Mol Pathol. 2007 Apr;82(2):220-6. Epub 2007 Jan 17.

PMID:
17208225
13.

Non-receptor type, proline-rich protein tyrosine kinase 2 (Pyk2) is a possible therapeutic target for Kawasaki disease.

Suzuki C, Nakamura A, Miura N, Fukai K, Ohno N, Yahata T, Okamoto-Hamaoka A, Fujii M, Yoshioka A, Kuchitsu Y, Ikeda K, Hamaoka K.

Clin Immunol. 2017 Feb 3;179:17-24. doi: 10.1016/j.clim.2017.01.013. [Epub ahead of print]

PMID:
28167306
14.

[Coronary arteritis induced by CAWS (Candida albicans water-soluble fraction) in various strains of mice].

Nagi-Miura N, Adachi Y, Ohno N.

Nihon Ishinkin Gakkai Zasshi. 2008;49(4):287-92. Review. Japanese.

15.

Effect of CAWS, a mannoprotein-beta-glucan complex of Candida albicans, on leukocyte, endothelial cell, and platelet functions in vitro.

Kurihara K, Shingo Y, Miura NN, Horie S, Usui Y, Adachi Y, Yadomae T, Ohno N.

Biol Pharm Bull. 2003 Feb;26(2):233-40.

16.

Histopathological features of murine systemic vasculitis caused by Candida albicans extract--an animal model of Kawasaki disease.

Takahashi K, Oharaseki T, Wakayama M, Yokouchi Y, Naoe S, Murata H.

Inflamm Res. 2004 Feb;53(2):72-7. Epub 2004 Jan 26.

PMID:
15021972
17.

β-mannosyl linkages inhibit CAWS arteritis by negatively regulating dectin-2-dependent signaling in spleen and dendritic cells.

Hirata N, Ishibashi K, Sato W, Nagi-Miura N, Adachi Y, Ohta S, Ohno N.

Immunopharmacol Immunotoxicol. 2013 Oct;35(5):594-604. doi: 10.3109/08923973.2013.830124. Epub 2013 Aug 28.

PMID:
23981001
18.
19.

The involvement of the vasa vasorum in the development of vasculitis in animal model of Kawasaki disease.

Hamaoka-Okamoto A, Suzuki C, Yahata T, Ikeda K, Nagi-Miura N, Ohno N, Arai Y, Tanaka H, Takamatsu T, Hamaoka K.

Pediatr Rheumatol Online J. 2014 Mar 30;12:12. doi: 10.1186/1546-0096-12-12.

20.

Interleukin-1β is crucial for the induction of coronary artery inflammation in a mouse model of Kawasaki disease.

Lee Y, Schulte DJ, Shimada K, Chen S, Crother TR, Chiba N, Fishbein MC, Lehman TJ, Arditi M.

Circulation. 2012 Mar 27;125(12):1542-50. doi: 10.1161/CIRCULATIONAHA.111.072769. Epub 2012 Feb 23.

Supplemental Content

Support Center